Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong · Delayed Price · Currency is HKD 1.130
0.00 (0.00%)
Jun 1, 2026, 3:59 PM HKT
HKG:2633 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 2,260 | 2,343 | 1,180 | 1,846 | 1,245 | 1,839 | |
Market Cap Growth | -5.93% | 98.55% | -36.07% | 48.24% | -32.29% | -32.30% |
Enterprise Value | 2,752 | 2,503 | 1,616 | 2,969 | 2,550 | 3,086 |
Last Close Price | 1.13 | 1.06 | 0.49 | 0.54 | 0.34 | 0.47 |
PE Ratio | 7.44 | 7.79 | 4.42 | 7.35 | 7.01 | 10.59 |
Forward PE | 8.25 | 7.37 | 7.37 | 7.37 | 7.37 | 7.22 |
PS Ratio | 1.47 | 1.49 | 0.80 | 1.46 | 0.78 | 1.27 |
PB Ratio | 1.00 | 0.95 | 0.49 | 0.57 | 0.42 | 0.64 |
P/TBV Ratio | 1.25 | 1.12 | 0.59 | 1.25 | 1.00 | 1.68 |
P/FCF Ratio | 9.61 | 8.42 | 3.33 | 3.26 | 3.63 | 5.32 |
P/OCF Ratio | 4.67 | 4.45 | 2.44 | 2.93 | 3.06 | 4.49 |
PEG Ratio | - | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
EV/Sales Ratio | 1.79 | 1.59 | 1.10 | 2.34 | 1.60 | 2.13 |
EV/EBITDA Ratio | 4.86 | 4.62 | 3.89 | 7.81 | 6.51 | 10.29 |
EV/EBIT Ratio | 6.59 | 5.78 | 5.19 | 11.03 | 10.26 | 18.78 |
EV/FCF Ratio | 11.70 | 8.99 | 4.55 | 5.24 | 7.43 | 8.92 |
Debt / Equity Ratio | 0.40 | 0.31 | 0.31 | 0.49 | 0.48 | 0.58 |
Debt / EBITDA Ratio | 1.61 | 1.34 | 1.65 | 3.83 | 3.23 | 4.70 |
Debt / FCF Ratio | 3.85 | 2.78 | 2.11 | 2.82 | 4.11 | 4.77 |
Net Debt / Equity Ratio | 0.21 | 0.09 | 0.12 | 0.16 | 0.30 | 0.39 |
Net Debt / EBITDA Ratio | 0.88 | 0.42 | 0.70 | 1.34 | 2.25 | 3.75 |
Net Debt / FCF Ratio | 1.99 | 0.81 | 0.82 | 0.90 | 2.57 | 3.25 |
Asset Turnover | 0.43 | 0.44 | 0.33 | 0.25 | 0.33 | 0.31 |
Inventory Turnover | 2.54 | 2.72 | 2.47 | 2.13 | 2.91 | 2.43 |
Quick Ratio | 0.90 | 1.27 | 1.73 | 2.12 | 1.05 | 0.92 |
Current Ratio | 1.41 | 1.88 | 2.59 | 2.68 | 1.43 | 1.33 |
Return on Equity (ROE) | 12.84% | 12.35% | 7.44% | 6.67% | 6.45% | 6.82% |
Return on Assets (ROA) | 7.26% | 7.59% | 4.39% | 3.32% | 3.23% | 2.17% |
Return on Invested Capital (ROIC) | 12.37% | 12.93% | 7.97% | 5.87% | 5.15% | 3.58% |
Return on Capital Employed (ROCE) | 14.60% | 14.00% | 10.00% | 5.70% | 6.30% | 4.10% |
Earnings Yield | 13.39% | 12.84% | 22.62% | 13.60% | 14.27% | 9.45% |
FCF Yield | 10.41% | 11.88% | 30.07% | 30.72% | 27.55% | 18.81% |
Dividend Yield | 8.63% | 8.46% | 11.19% | 9.68% | 11.54% | 4.86% |
Payout Ratio | 118.78% | 19.80% | 35.06% | 41.44% | 29.11% | 36.39% |
Buyback Yield / Dilution | -1.80% | -3.42% | -0.45% | 0.21% | 0.03% | 3.37% |
Total Shareholder Return | 6.82% | 5.04% | 10.75% | 9.88% | 11.57% | 8.23% |